236 related articles for article (PubMed ID: 26553452)
1. ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.
Chiu KL; Kuo TT; Kuok QY; Lin YS; Hua CH; Lin CY; Su PY; Lai LC; Sher YP
Sci Rep; 2015 Nov; 5():16426. PubMed ID: 26553452
[TBL] [Abstract][Full Text] [Related]
2. ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.
Chiu KL; Lin YS; Kuo TT; Lo CC; Huang YK; Chang HF; Chuang EY; Lin CC; Cheng WC; Liu YN; Lai LC; Sher YP
Oncotarget; 2017 Jul; 8(29):47365-47378. PubMed ID: 28537886
[TBL] [Abstract][Full Text] [Related]
3. ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells.
Sher YP; Wang LJ; Chuang LL; Tsai MH; Kuo TT; Huang CC; Chuang EY; Lai LC
PLoS One; 2014; 9(4):e94065. PubMed ID: 24705471
[TBL] [Abstract][Full Text] [Related]
4. ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.
Lin CY; Chen HJ; Huang CC; Lai LC; Lu TP; Tseng GC; Kuo TT; Kuok QY; Hsu JL; Sung SY; Hung MC; Sher YP
Cancer Res; 2014 Sep; 74(18):5229-43. PubMed ID: 25060522
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pulmonary carcinoma proliferation or metastasis of miR-218 via down-regulating CDCP1 expression.
Zeng XJ; Wu YH; Luo M; Cong PG; Yu H
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1502-1508. PubMed ID: 28429357
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma.
Geng F; Lu GF; Luo YJ; Dominguez S; Kong DY; Shen LH; Luo XM; Yang X; Hu M; Lai WS; Jiang ZS; Chen YS
Aging (Albany NY); 2020 Nov; 13(1):894-909. PubMed ID: 33260155
[TBL] [Abstract][Full Text] [Related]
7. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
Wang FF; Wang S; Xue WH; Cheng JL
Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
9. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
11. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
[TBL] [Abstract][Full Text] [Related]
12. microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.
Tang Y; Liu X; Su B; Zhang Z; Zeng X; Lei Y; Shan J; Wu Y; Tang H; Su Q
Mol Med Rep; 2015 Jan; 11(1):454-60. PubMed ID: 25323629
[TBL] [Abstract][Full Text] [Related]
13. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
14. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
15. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
[TBL] [Abstract][Full Text] [Related]
16. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
17. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
[TBL] [Abstract][Full Text] [Related]
19. Regulation of inside-out β1-integrin activation by CDCP1.
Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
[TBL] [Abstract][Full Text] [Related]
20. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]